Citation: | GUO Qianqian. Advances in the research of paclitaxel nanoliposomes[J]. Journal of China Pharmaceutical University, 2014, 45(5): 599-606. DOI: 10.11665/j.issn.1000-5048.20140517 |
[1] |
Utreja P, Jain S, Tiwary AK.玈 Localized delivery of paclitaxel using elastic liposomes formulation development and evaluation[J]. Drug Deliv,2011,18(5):367-376.
|
[2] |
Guo T,Sun FD,Gao SC,et al.Study on 2-hydroxpropyl-β-cyclodextrin paclitaxel inclusion compound[J].China Pharm(中国药师),2012,15(1):3-6.
|
[3] |
Huo MR,Zhang Y,Zhou JP,et al.Preparation of paclitaxel-loaded chitosan self-assembled nanomicelles freeze-dried powder for injection and its physicochemical characterization[J].Chin Pharm J(中国药学杂志),2009,44(3):199-204.
|
[4] |
Tian H,Jin YH,Chen YJ,et al.Modification of taxol with amino acids derivatives of polyethylene glycol[J].J China Pharm Univ(中国药科大学学报),2011,42(1):78-82.
|
[5] |
Liu W,Guo T,Ge JW,et al.An oligopeptide improves solubility of paclitaxel by non-covalent interaction[J].Acta Pharm Sin(药学学报),2012,47(7):947-952.
|
[6] |
Wang J,Huo MR,Zhou JP,et al.Drugs-loaded micelles based on hyaluronic acid-paclitaxel prodrug:preparation and pharmacokinetic study in rats[J].J China Pharm Univ(中国药科大学学报),2013,44(6):520-525.
|
[7] |
Sun J, Ju CY, Zhang C. Preparation and anti-tumor activity of paclitaxel thermo-sensitive hydrogel[J].J China Pharm Univ(中国药科大学学报),2012,43(5):424-429.
|
[8] |
Mo QQ, Chen PB, Jin X, et al. Inhibition of Hecl expression enhances the sensitivity of human ovarian cancer cells to paclitaxel[J].Acta Pharmacol Sin(中国药理学报),2013,34(4):541-548.
|
[9] |
Zhou J,Zhao WY,Ma X,et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer[J].Biomaterials,2013,34(14):3 626-3 638.
|
[10] |
Liu SL,Liu SY,Zhang HH.Study on the preparation of paclitaxel liposome and the tropism for the brain targeted therapy[J].China J Hosp Pharm(中国医院药学杂志),2012,32(24):1 979-1 983.
|
[11] |
Wang X,Song L,Li N,et al.Pharmacokinetics and biodistribution study of paclitaxel liposome in Sprague-Dawley rats and Beagle dogs by liquid chromatography-tandem mass spectrometry[J]. Drug Res,2013,63(11):603-606.
|
[12] |
Liu YJ,Liu CX,Li M,et al.Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers:poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)to enhance paclitaxel target delivery[J]. J Biomed Nanotechnol,2014,10(6):948-958.
|
[13] |
Wang YF,Chang ZF,Wang H,et al.Immunosuppressive effect of paclitaxel liposome on B lymphocytes[J].Chin New Drugs J(中国新药杂志),2009,18(24):2 345-2 348.
|
[14] |
Zhao JG,Wang JF,Wu DP,et al.Clinical observation of paclitaxel liposome combined with capecitabine in the first-line treatment of advanced gastric cancer[J].J China Pharm(中国药房),2010,21(14):1 313-1 315.
|
[15] |
Suo T,Ge W,Zhang JZ,et al.17 cases of advanced non-small cell lung cancer treated with paclitaxel liposome plus nedaplatin[J].Chin Ger J Clin Oncol,2012,11(4):196-198.
|
[16] |
Zhou CC,Meng SY,Zhou W,et al.A dual targeting tumor paclitaxel nanoliposome and its preparation method:CN,102166190A[P].2011-08-31[2014-04-24]
|
[17] |
Luo LM,Huang Y,Zhao BX,et al.Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel[J]. Biomaterials,2013,34(4):1 102-1 114.
|
[18] |
Meng SY,Su B,Li W,et al.Integrin-targeted paclitaxel nanoliposomes for tumor therapy [J].Med Oncol,2011,28(4):1 180-1 187.
|
[19] |
Liang Q,Liang L,Han JW,et al.One kind of immune nanoliposomes paclitaxel and its preparation method and uses:CN,102379848 A[P].2012-03-21[2014-04-24]
|
[20] |
Zhao M,Chang J,Fu XP,et al.Nano-sized cationic polymeric magnetic liposomes significantly improves drug delivery to the brain in rats [J].J Drug Target,2012,20(5):416-421.
|
[21] |
Xin SC,Wu XR,Zhou LZ.Preparation of magnetic solid liposome nanoparticles of paclitaxel[J].Acta Pharm Sin(药学学报),2006,41(10):933-938.
|
[22] |
Qian XZ,Xu YL,Han WY,et al.One kind of folic acid-carboxymethyl chitosan modified pH sensitive nanoliposome to paclitaxel:CN,102488658A[P].2012-06-13[2014-04-24]
|
[23] |
Li Q,Li M,Jin GY,et al.Preparation and in vitro anti-cancer effect of paclitaxel-loaded pH-sensitive block copolymer micelles[J].J Int Pharm Res,2013,40(2):233-241.
|
[24] |
Xu D,Gong W,Liu N,et al.Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensitive liposomes in rats[J].Chin Pharm J(中国药学杂志),2012,47(22):1 839-1 843.
|
[25] |
Shen ZT,Yang N,Yu LX,et al.The LD50 and difference of paclitaxel and docetaxel thermosensitive nano-micelle[J].Jiangsu Med J(江苏医药),2008,34(1):56-58.
|
[26] |
Nie S,Hsiao WL,Pan W,et al.Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release,cell cytotoxicity,and uptake studies[J].Int J Nanomed,2011,6:151-166.
|
[27] |
Zhang YY,Fu XD,Liu KD,et al.Preparation and tumor targeting of NGR-SWCNTs-paclitaxel[J].Chin Pharm J(中国药学杂志),2013,48(20):1 748-1 754.
|
[28] |
Shvedova AA,Castranova V,Kisin ER,et al.Exposure to carbon nanotube material:assessment of nanotube cytotoxicity using human keratinocyte cells[J].J Toxicol Environ Health A,2003,66(20):1 909-1 926.
|
[29] |
Huo MR,Zhou JP,Wei Y,et al.Preparation of paclitaxel loaded cationic chitosan micelles and study of its biodistribution in mice[J].J China Pharm Univ(中国药科大学学报),2006,37(2):132-136.
|
[30] |
Ji DY,Wu QZ,Ping QN.Synthesis of PLA-mPEG and preparation of docetaxel of polymer micelles[J].J China Pharm Univ(中国药科大学学报),2008,39(3):223-227.
|
[31] |
Tan Y,Zhou JP,Tong XY,et al.Pharmacokinetics of F-68 modified paclitaxel liposomes in rats[J].J China Pharm Univ(中国药科大学学报),2006,37(3):230-232.
|
[32] |
Li WT,Wang L,Zhang C.Influence of surface characteristics on hepatocellular carcinoma cells uptake of nano-liposomes[J].J China Pharm Univ(中国药科大学学报),2013,44(3):244-248.
|
[33] |
Li SB,Liu D,Ning H,et al.Determination of entrapment efficiency of paclitaxel solid lipid nanoparticles[J].Chin Pharm J(中国药学杂志),2008,43(21):1 665-1 668.
|
[34] |
Zhang L,Li YH,Wang CX,et al.Preparation of liposomal paclitaxel and its toxicity and antitumor effect[J].Chin Pharm J(中国药学杂志),2013,48(6):446-449.
|
[35] |
Zhong C,Xiu LY;Yu SJ,et al.Modulation of release of paclitaxel from composite cerasomes[J]. Colloids Surf B Biointerfaces,2012,98:97-104.
|
[36] |
Wang SJ,Hou W,Sun K,et al.Effects of several auxiliary materials on the particle size and Zeta potential of paclitaxel liposome[J]. Med Plant,2011,2(10):52-55.
|
[37] |
Mei L,Song CX,Jin X,et al.Surface modified paclitaxel loaded nanoparticles as local delivery system for the prevention of vessel restenosis[J].Acta Pharm Sin(药学学报),2007,42(1):81-86.
|
[38] |
Liu D,Li SB,Bao J,et al.Preparation in vitro release and pharmacokinetics of paclitaxel lipid nanoparticles for intravenous injection[J].Chin Pharm J(中国药学杂志),2009,44(17):1 320-1 326.
|
[39] |
Ma YL,Ye J,Zhang PX,et al.Comparative study on pharmacokinetics and tissue distribution of a novel microemulsion based on the paclitaxel/L-OH lipid complex and paclitaxel injection in cremophor[J].Acta Pharma Sin(药学学报),2013,48(11):1 698-1 704.
|
[40] |
Li XM,Cheng XD,Wang YL,et al.Prepatation of paclitaxel nanosuspension and study of its pharm acokinetic and biodistribution behavior in rats[J].Chin Pharm J(中国药学杂志),2011,46(9):680-685.
|
[41] |
Tang Y,Li J,Zhang YD.Anticancer effect of long-circulating nanoliposome packaging paclitaxel in vitro and in vivo[J].China J Mod Med(中国现代医学杂志),2012,22(10):29-32.
|
[42] |
Meng SY,Zhou CC,Su B,et al.Preparation and characterization of PEGylated paclitaxel liposomes[J].Prog Mod Biomed(现代医学生物进展)2009,9(13):2 407-2 409.
|
[43] |
Yan F,Li L,Deng ZT,et al.Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers[J].J Control Release,2013,166(3):246-255.
|
[44] |
Patel NR,Rathi A,Mongayt D,et al.Reversal of multidrug resistance by co-delivery of tariquidar(XR9576)andpaclitaxel using long-circulating liposomes[J].Int J Pharm,2011,416(1):296-299.
|
[45] |
Gao L,Liu GY,Ma JL,et al.Studies on pharmacokinetices and acute toxieity of paclitaxel nanosuspensions[C].Beijing:2012 Chinese Pharmaceutical Conference Abstract,2013:277-281.
|
[46] |
Ji XF,Gao Y,Chen LL,et al.Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance[J].Int J Pharm,2012,422(1/2):390-397.
|
[47] |
Xu C, Jiang SG, Gong XF, et al. Nano-paclitaxel transport by human intestinal epithelial Caco-2 cells[J]. Bull Botanical Res,2013,33( 3):339-345.
|
[48] |
Cui YN, Ge JJ, Li LB. Preparation of paclitaxel-loaded mixed micelles and enhancement on oral absorption of paclitaxel[J].J Shandong Univ(Health Sci)(山东大学学报 医学版),2012,50(11):107-112.
|
[49] |
Li CC,Zhang ZH,Zhang YL,et al.In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides[J].Acta Pharma Sin(药学学报),2013,48(1):131-137.
|
[50] |
Peng L,Kong Y,Liu SJ,et al.A rapid liquid chromatography-tandem mass spectrometry method for determination of paclitaxel in plasma[J].Chin Hosp Pharm J(中国医院药学杂志),2013,33(20):1 682-1 685.
|
[51] |
Ye DM,Chen XY,Lan S.Comparison of liver injury degree in mice induced by 6 kinds of com mon antineoplastic drugs[J].J China Pharm(中国药房),2011,22(29):2 720-2 722.
|
[52] |
Solomon MA, Shah AA, D′Souza GG. In vitro assessment of the utility of stearyl triphenyl phosphonium modified liposomes in overcoming the resistance of ovarian carcinoma Ovcar-3 cells to paclitaxel [J]. Mitochondrion,2013,13(5):464-472.
|
[53] |
Yan Z,Xia LP,Qiu HJ,et al.Short-term outcomes of albumin-bound paclitaxel(abraxane)-containing chemotherapy in patients with advanced gastric cancer:a report of 14 cases[J].Chin Ger J Clin Oncol,2013,12(1):30-34.
|
[54] |
Shao JC,Lin HX,Cui YM,et al.Design,synthesis and evaluation of the cytotoxicity of a N-mustard and paclitaxel conjugate prodrug [J].J Chin Pharm Sci(中国药学),2013,22(2):137-143.
|
[55] |
Zhang Q,Huang XE,Gao LL.Safety of pretreatment protocols of paclitaxel liposome[J].J China Pharm(中国药房),2009,20(11):841-843.
|
[56] |
Shao CY,Li JP,Tu JS.In vitro stability of paclitaxel and docetaxel binary-drug loaded in micelles[J].J China Pharm Univ(中国药科大学学报),2010,41(5):428-434.
|
[1] | LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603 |
[2] | WANG Zhenghao, GAO Yafeng, ZHANG Lianjun, LIU Chang. Research progress of T cell anti-tumor function regulated by endoplasmic reticulum stress[J]. Journal of China Pharmaceutical University, 2022, 53(5): 518-524. DOI: 10.11665/j.issn.1000-5048.20220502 |
[3] | LIU Li, ZHANG Qianwen, NONG Cheng, ZHANG Xi, XU Xiaoting, Mohammed Ismail, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin. Research progress of lncRNA regulating signal transduction pathway in liver diseases[J]. Journal of China Pharmaceutical University, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304 |
[4] | SHI Jinyu, BAI Ying, PENG Kewen, ZHANG Wenhui, ZHU Qihua, XU Yungen. Research progress of PARP-1 inhibitors in combination with other drugs to overcome drug resistance[J]. Journal of China Pharmaceutical University, 2019, 50(5): 523-530. DOI: 10.11665/j.issn.1000-5048.20190503 |
[5] | YUE Yali, YIN Jun, GAO Xiangdong, YAO Wenbing. Research advances of bispecific antibody drugs in tumor therapy[J]. Journal of China Pharmaceutical University, 2019, 50(3): 289-298. DOI: 10.11665/j.issn.1000-5048.20190304 |
[6] | MEI Liankuo, WEI Qiangqiang, ZHANG Huibin, ZHOU Jinpei. Research progress in acetyl-CoA carboxylase inhibitors[J]. Journal of China Pharmaceutical University, 2019, 50(3): 253-264. DOI: 10.11665/j.issn.1000-5048.20190301 |
[7] | JIA Chengshu, WANG Junwei, LI Hui, ZHU Qihua, GE Yiran, XU Yungen. Advances of phosphoinositide-3 kinase inhibitors in combination with other drugs to overcome drug resistance[J]. Journal of China Pharmaceutical University, 2017, 48(5): 523-528. DOI: 10.11665/j.issn.1000-5048.20170503 |
[8] | WANG Chen, XU Jun, LIU Yanhua, WANG Zengtao, HU Yue, TIAN Taiping, YI Mengjuan. Research progress on functionalized graphene oxide as drug carriers[J]. Journal of China Pharmaceutical University, 2017, 48(1): 117-124. DOI: 10.11665/j.issn.1000-5048.20170118 |
[9] | ZHANG Danfeng, JIAO Yu, LIU Yong, ZHANG Yanmin, ZHANG Zhimin, LU Tao. Progress of small molecule anti-tumor covalent drugs[J]. Journal of China Pharmaceutical University, 2017, 48(1): 1-7. DOI: 10.11665/j.issn.1000-5048.20170101 |
[10] | HU Yue, CHEN Zhou, LUO Xiaoxing, XUE Xiaoyan. Research progress of 1, 2-dilinoleyloxy-3-dimethylaminopropane-based cationic lipid nanoparticle[J]. Journal of China Pharmaceutical University, 2016, 47(1): 112-117. DOI: 10.11665/j.issn.1000-5048.20160117 |